A new study has suggested that the economic burden posed by rare diseases is around 10 times higher than for common "mass market" conditions. The analysis by IQVIA and pharma company Chiesi looked at ...
Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development. Somer G.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback